Association of early therapeutic drug monitoring of adalimumab with biologic remission and drug survival in Crohn’s Disease

Association of early therapeutic drug monitoring of adalimumab with biologic remission and drug survival in Crohn’s Disease

Background: Therapeutic drug monitoring of adalimumab (ADA) is still controversial. Objectives: To study the association between ADA trough levels in the early stages of treatment with biological remission (BR) and drug survival in Crohn’s disease (CD). Design: Retrospective cohort study. Methods: P...

Full description

Saved in:
Bibliographic Details
Main Authors: José Luis Rueda García, Cristina Suárez-Ferrer, Clara Amiama Roig, Laura García Ramírez, Cristina García Rojas, Eduardo Martín-Arranz, Joaquín Poza Cordón, María Sánchez Azofra, Jesús Noci, Cristina Cubillo García, María Dolores Martín-Arranz
Format: Article
Language:English
Published: SAGE Publishing 2025-03-01
Series:Therapeutic Advances in Gastroenterology
Online Access:https://doi.org/10.1177/17562848251324226
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1177/17562848251324226

Similar Items